Immunic
IMUX
$1.42
Share price
1.83%
Change (1 day)
-29.58%
Change (1 year)
Categories
Immunic (IMUX) - Cash on Hand
Cash on Hand as of December 2024 : A$56.33 Million
According to Immunic's latest financial reports the company has A$56.33 Million in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Immunic - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | A$68.5 M | -59.94% |
| 2022-12-31 | A$0.17 B | 42.73% |
| 2021-12-31 | A$0.11 B | -27.71% |
| 2020-12-31 | A$0.16 B | 295.14% |
| 2019-12-31 | A$41.94 M | 121.79% |
| 2018-12-31 | A$18.91 M | -74.05% |
| 2017-12-31 | A$72.88 M | -12.43% |
| 2016-12-31 | A$83.22 M | -27.32% |
| 2015-12-31 | A$0.11 B | -8.34% |
| 2014-12-31 | A$0.12 B | 191.81% |
| 2013-12-31 | A$42.81 M | 140.83% |
| 2012-12-31 | A$17.77 M | 2169.83% |
| 2011-12-31 | A$0.78 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | A$0.40 B | 617.62% | 🇺🇸 USA |